Pages that link to "Q54684597"
Jump to navigation
Jump to search
The following pages link to Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. (Q54684597):
Displaying 50 items.
- Mycophenolate mofetil versus methotrexate for prevention of graft-versus-host disease in people receiving allogeneic hematopoietic stem cell transplantation (Q24194807) (← links)
- Polyclonal anti-thymocyte globulins for the prophylaxis of graft-versus-host disease after allogeneic stem cell or bone marrow transplantation in adults (Q24200813) (← links)
- Mycophenolate mofetil versus methotrexate for prevention of acute graft-versus-host disease in patients receiving allogeneic hematopoietic stem cell transplantation (Q24202699) (← links)
- Tacrolimus versus cyclosporine A for prevention of graft versus host disease after stem cell transplantation (Q26472072) (← links)
- Graft-versus-host disease: why have we not made more progress? (Q27012940) (← links)
- The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease (Q28076264) (← links)
- NIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group Report (Q28081289) (← links)
- Pulmonary function changes in long-term survivors of bone marrow transplantation (Q28290958) (← links)
- Outcomes after Umbilical Cord Blood Transplantation for Myelodysplastic Syndromes (Q30252975) (← links)
- Allogeneic Hematopoietic Cell Transplantation for Adult Chronic Myelomonocytic Leukemia (Q30274942) (← links)
- Impact of pre-transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation (Q30274960) (← links)
- Low CD34 dose is associated with poor survival after reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia and myelodysplastic syndrome (Q30371042) (← links)
- Does total body irradiation conditioning improve outcomes of myeloablative human leukocyte antigen-identical sibling transplantations for chronic lymphocytic leukemia? (Q30407633) (← links)
- Tacrolimus (FK506) and methotrexate as prophylaxis for acute graft-versus-host disease in pediatric allogeneic stem cell transplantation (Q31418325) (← links)
- Virological, clinical, and ophthalmologic features of cytomegalovirus retinitis after hematopoietic stem cell transplantation (Q31918003) (← links)
- Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acute graft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicities (Q33335306) (← links)
- Allogeneic blood stem cell transplantation after a reduced-intensity, preparative regimen: a pilot study in patients with refractory malignancies (Q33342453) (← links)
- Clinical grading in chronic graft-versus-host disease: is it time for change? (Q33343489) (← links)
- Performance of a new clinical grading system for chronic graft-versus-host disease: a multicenter study (Q33347659) (← links)
- Intestinal thrombotic microangiopathy after allogeneic bone marrow transplantation: a clinical imitator of acute enteric graft-versus-host disease. (Q33360369) (← links)
- Transplantation outcome in allogeneic PBSCT patients according to a new chronic GVHD grading system, including extensive skin involvement, thrombocytopenia, and progressive-type onset (Q33360712) (← links)
- Clinical significance of platelet count at day +60 after allogeneic peripheral blood stem cell transplantation (Q33370269) (← links)
- Chronic graft-versus-host disease: Pathogenesis and clinical management. (Q33371639) (← links)
- Prolonged thrombocytopenia after allogeneic hematopoietic stem cell transplantation: associations with impaired platelet production and increased platelet turnover (Q33372286) (← links)
- New clinical grading system for chronic GVHD predicts duration of systemic immunosuppressive treatment and GVHD-specific and overall survival (Q33374835) (← links)
- Clinical utility of rituximab in chronic graft-versus-host disease (Q33383124) (← links)
- Pegfilgrastim compared to lenograstim after allogeneic peripheral blood stem-cell transplantation from unrelated donors (Q33383573) (← links)
- Rituximab for the treatment of corticosteroid-refractory chronic graft-versus-host disease (Q33385079) (← links)
- Prophylaxis with Sirolimus and Tacrolimus ± Antithymocyte Globulin Reduces the Risk of Acute Graft-versus-Host Disease without an Overall Survival Benefit Following Allogeneic Stem Cell Transplantation (Q33392218) (← links)
- Transplantation-associated thrombotic microangiopathy after steroid pulse therapy for polyserositis related to graft-versus-host disease (Q33393068) (← links)
- Allogeneic haematopoietic stem cell transplantation for myelofibrosis: a report of the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC). (Q33393151) (← links)
- Evaluation of schistocyte monitoring after haematopoietic stem cell transplantation (Q33393944) (← links)
- Significantly worse survival of patients with NIH-defined chronic graft-versus-host disease and thrombocytopenia or progressive onset type: results of a prospective study (Q33397272) (← links)
- Thrombotic microangiopathy associated with sirolimus level after allogeneic hematopoietic cell transplantation with tacrolimus/sirolimus-based graft-versus-host disease prophylaxis (Q33403897) (← links)
- Safety and efficacy of low-dose methotrexate for pediatric patients with steroid-refractory acute graft-versus-host disease after hematopoietic stem cell transplantation (Q33411063) (← links)
- Incidence and risk factors for life-threatening bleeding after allogeneic stem cell transplant. (Q33421514) (← links)
- Desialylation is associated with apoptosis and phagocytosis of platelets in patients with prolonged isolated thrombocytopenia after allo-HSCT. (Q33427006) (← links)
- Characterization of thrombopoietin kinetics within 60 days after allogeneic hematopoietic stem cell transplantation and its correlation with megakaryocyte ploidy distribution (Q33427735) (← links)
- A risk factor analysis of outcomes after unrelated cord blood transplantation for children with Wiskott-Aldrich syndrome (Q33439801) (← links)
- Delayed platelet recovery after allogeneic hematopoietic stem cell transplantation: Association with chronic graft-versus-host disease and survival outcome (Q33441641) (← links)
- The Japanese cord blood bank network experience with cord blood transplantation from unrelated donors for haematological malignancies: an evaluation of graft-versus-host disease prophylaxis (Q33445489) (← links)
- The impact of immunogenetics and clinical factors on the outcome of unrelated cord blood transplantation: the Milano Cord Blood Bank data (Q33452455) (← links)
- Acute renal failure in the setting of bone marrow transplantation (Q33490414) (← links)
- High-dose etoposide, cyclophosphamide and total body irradiation with allogeneic bone marrow transplantation for resistant acute myeloid leukemia: a study by the North American Marrow Transplant Group (Q33496924) (← links)
- Hematopoietic stem cell transplantation: a primer for the primary care physician (Q33555232) (← links)
- Allogeneic transplantation for primary myelofibrosis with BM, peripheral blood or umbilical cord blood: an analysis of the JSHCT (Q33556843) (← links)
- Allogeneic hematopoietic stem cell transplantation in patients with polycythemia vera or essential thrombocythemia transformed to myelofibrosis or acute myeloid leukemia: a report from the MPN Subcommittee of the Chronic Malignancies Working Party o (Q33558748) (← links)
- HLA-haploidentical donor lymphocyte infusions for patients with relapsed hematologic malignancies after related HLA-haploidentical bone marrow transplantation (Q33566388) (← links)
- Rationale and design of the chronic GVHD cohort study: improving outcomes assessment in chronic GVHD (Q33591662) (← links)
- Outcomes of related donor HLA-identical or HLA-haploidentical allogeneic blood or marrow transplantation for peripheral T cell lymphoma (Q33608520) (← links)